Ms Jeanna Wacker > Kirkland & Ellis LLP > New York, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
![Kirkland & Ellis LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/53108.jpg?v=1653404167)
601 LEXINGTON AVENUE
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Ms Jeanna Wacker
![Jeanna Wacker photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/07/53108_1160846.jpg)
Position
Jeanna Wacker is a partner in the New York office of Kirkland & Ellis LLP. She is an experienced trial lawyer and concentrates her practice on patent litigation in the life sciences field. Jeanna has extensive experience representing clients in the pharmaceutical, biotechnology, chemical and medical device industries and has represented both plaintiffs and defendants at all stages of litigation, including trials (bench and jury) and appeal. Jeanna also has experience in inter partes reviews before the United States Patent and Trademark Office. Her clients have included some of the largest companies in the life sciences area such as, Bristol-Myers Squibb, Hoffman La-Roche, Boehringer Ingelheim, Teva Pharmaceuticals, Pfizer, E.I. du Pont de Nemours, and Novartis Pharmaceuticals. Jeanna has established a reputation as a leading litigator in the life sciences field and is regularly invited to speak on hot topics in this area.
Jeanna is also regularly called upon to advise pharmaceutical and biotech companies on intellectual property aspects of corporate merger agreements and product acquisitions.
Lawyer Rankings
United States > Healthcare > Life sciences
Kirkland & Ellis LLP‘s life sciences work brings together a number of the firm’s departments, together handling antitrust proceedings in the sector, while also representing pharmaceutical companies in product liability and personal injury litigation. Such disputes are the domain of Jay Lefkowitz, who also handles False Claims Act and shareholder litigation before Circuit Courts of Appeal and the Supreme Court. Further antitrust litigation experience comes in the form of Devora Allon, who also handles a broad range of commercial litigation. Patent litigation covering pharmaceuticals, medical devices and biotechnology is handled by Jeanna Wacker, and she is also consulted on the IP aspects of corporate and asset transactions. All lawyers mentioned are based in New York.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism